Cargando…
Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome
The euglycemic–hyperinsulinemic clamp is not available in most clinical settings. An accessible and inexpensive measurement for identifying insulin resistance (IR) is necessary. Our aim is to assess whether the adiponectin (ADI) index (ADI/[FBG × FIns]) is a better surrogate index for the assessment...
Autores principales: | Xu, Xiaohui, Lai, Yerui, Yang, Gangyi, Yang, Mengliu, Li, Ling, Zhang, Qin, Liu, Hua, Zheng, Hongting, Zhu, Danping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266016/ https://www.ncbi.nlm.nih.gov/pubmed/27930544 http://dx.doi.org/10.1097/MD.0000000000005524 |
Ejemplares similares
-
Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome
por: Lai, Yerui, et al.
Publicado: (2016) -
Serum calprotectin levels as markers of inflammation, insulin resistance and hyperandrogenism in women with polycystic ovary syndrome
por: Hancerliogullari, Necati, et al.
Publicado: (2022) -
Tanshinone for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Yang, Yijiao, et al.
Publicado: (2021) -
Metformin and acupuncture for polycystic ovary syndrome: A protocol for a systematic review and meta-analysis
por: Gao, Yang, et al.
Publicado: (2020) -
Reporting quality of polycystic ovary syndrome practice guidelines based on the RIGHT checklist
por: Li, Hongzhu, et al.
Publicado: (2020)